Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Ectodermal dysplasia with immune deficiency (EDI) is linked to mutations in the NEMO gene, affecting NF-κB signaling pathways.
• NF-κB essential modulator (NEMO), also known as IκB kinase γ subunit (IKKγ), is crucial for immune responses and development.
• Previous research focused on NEMO coding sequence mutations causing EDI.

Observation:

• Two unrelated male patients with EDI presented with normal NEMO coding sequences but significantly reduced full-length NEMO protein levels.
• Toll-like receptor 4 (TLR4) stimulation in antigen-presenting cells (APCs) from these patients showed normal NF-κB activation and nuclear translocation.
• Despite normal NF-κB translocation, these cells exhibited defective expression of NF-κB-regulated cytokines like IL-12.

Findings:

• Patients' cells showed impaired expression of NF-κB-regulated cytokines, indicating a downstream defect in transcription.
• Specifically, TLR4-stimulated APCs lacked IKKα-dependent H3 histone phosphorylation at the IL-12 promoter.
• Recruitment of NF-κB heterodimers (RelA and cRel) to the IL-12 promoter was also defective in patient cells.
• Restoring IKKα activity in a NEMO-deficient cell line rescued IL-12 production, highlighting IKKα's role.

Implications:

• NEMO plays a critical role in regulating the nuclear function of IKKα, extending beyond its known role in NF-κB complex activation.
• These findings suggest a novel mechanism for EDI pathogenesis involving impaired chromatin accessibility for NF-κB transcription factors.
• This research provides new insights into the molecular basis of diminished NF-κB signaling in EDI patients, potentially opening avenues for targeted therapies.